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As human genomics moves into a mass-
scale era, whereby millions of genome
sequences will soon become available, new
opportunities are opening up to use these
very large samples better to understand the
relationship between genotype and pheno-
type.
A fundamental problem for such stud-
ies in the past has been lack of standardiza-
tion in the description of the phenotypes
used. Not only have disease concepts often
been confused with phenotypes (most dis-
eases manifest numerous, distinct pheno-
types which not only makes up the disease
description but often can be observed in a
number of diseases), but the concepts used
have at times been vague (Hancock et al.,
2009; Schofield et al., 2010).
In addition, model organisms are fre-
quently used to study disease-, and more
broadly phenotype-related phenomena in
systems with applicability to humans but
which are not subject to equivalent ethi-
cal problems or issues of data protection.
A key requirement for future computa-
tional analysis of the relationship between
genotype and phenotype in human will
therefore be to include knowledge from
model organisms (Hancock et al., 2009).
Significant progress has been made
in using ontologies to describe human
and model organism phenotypes in
recent years. Many computational biology
communities, serving particular model
organism experimental communities,
have developed approaches to the onto-
logical description of phenotypes, often
associated with community databases. As
an example, the Mammalian Phenotype
ontology (MP) (Smith and Eppig, 2012)
was developed in association with the
Mouse Genome Database (Blake et al.,
2014) to facilitate consistent annotation
of phenotypes associated with genomic
differences. The MP, although originally
developed for mouse, was subsequently
applied to rat in the context of the Rat
Genome Database (Nigam et al., 2013).
For humans the Human Phenotype
Ontology (HPO) (Kohler et al., 2014)
has been developed to reflect the atomic
features of diseases, initially making use of
the OMIM (OnlineMendelian Inheritance
in Man) resource (Amberger et al., 2011).
A drawback of these approaches to
ontological description, whichmake use of
so-called pre-composed ontologies which
are prepared in advance to the annotation
process, is that they are unable to represent
the full range of phenotypic observations
including “normal” states, or of represent-
ing subtle differences or numerical values.
To address this, an alternative approach,
often known as the PATO (Phenotype
and Trait Ontology) approach, has been
developed (Bard and Rhee, 2004; Gkoutos
et al., 2004, 2009). This aims to make
use of a group of compatible ontologies
to produce combinatorial expressions of
the type:
Entity E has attribute A of value V when
measured in organism O using test T under
conditions C.
where elements in bold are terms from
an appropriate ontology. The full imple-
mentation of such an approach is yet to be
realized, although starts have beenmade in
databases such as Zfin (Howe et al., 2013)
and Europhenome (Morgan et al., 2010).
A key missing element in such a
compositional approach is standard
descriptions of experimental methods
and conditions. Over the last decade or
so a number of ontological approaches
to defining experimental conditions have
been developed. The MGED Ontology
(Whetzel et al., 2006b) was devel-
oped to underpin the fulfillment of the
MIAME (Minimum Information About a
Microarray Experiment) metadata criteria
(Brazma et al., 2001). The HUPO (Human
Proteome Organization) PSI (Proteomics
Standards Initiative) Mass Spectroscopy
Vocabularies (Mayer et al., 2013) facil-
itate the description of experiments in
proteomics and mass spectroscopy. The
Metabolomics Standards Initiative has
established COSMOS (COordination of
Standards in MetabOlomicS) (Steinbeck
et al., 2012) to describe metabolomics
experiments, making use of the ISA
(Investigation/Study/Assay) framework
(Sansone et al., 2012). FuGO (the
Functional Genomics Investigation
Ontology) was developed to provide a
broader structure for functional genomics
experiments (Whetzel et al., 2006a). EXPO
(Soldatova and King, 2006) attempts to
provide a higher level ontology to which
such domain-specific ontologies can be
integrated.
An important addition to the armory
of ontological frameworks that can be
used to describe phenotypes is provided
by Shimoyama et al. (2012) who describe
a set of three ontologies that can be used
to describe clinical measurements, mea-
surement methods and experimental con-
ditions for traits common to rat and man
(and, by extension, to other mammalian
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model systems such as mouse and, poten-
tially, more distantly related species). Their
approach extends the availability of exper-
imental description ontologies in a whole
new direction and, crucially the types
of measurement they can describe using
these ontologies are similar to those
used in large-scale phenotyping experi-
ments on mouse models of human dis-
ease (Hancock and Dobbie, 2014). Their
ontology system can be used to describe
both human and model mammal phe-
notyping measurements (T and C in the
above expression). It therefore provides
an underpinning component for the com-
putational study of genotype-phenotype
relations in humans and model mammals.
At the same time it provides a valuable
set of terms and relations to facilitate
more systematic annotation and search-
ing of phenotype terms across human and
model organism databases. This opens up
exciting new opportunities for the unified
analysis of human and mouse disease and
phenotype data.
REFERENCES
Amberger, J., Bocchini, C., and Hamosh, A. (2011). A
new face and new challenges for Online Mendelian
Inheritance in Man (OMIM(R)). Hum. Mutat. 32,
564–567. doi: 10.1002/humu.21466
Bard, J. B., and Rhee, S. Y. (2004). Ontologies in
biology: design, applications and future chal-
lenges. Nat. Rev. Genet. 5, 213–222. doi: 10.1038/
nrg1295
Blake, J. A., Bult, C. J., Eppig, J. T., Kadin, J. A.,
and Richardson, J. E. (2014). The Mouse Genome
Database: integration of and access to knowledge
about the laboratory mouse. Nucleic Acids Res. 42,
D810–D817. doi: 10.1093/nar/gkt1225
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock,
G., Spellman, P., Stoeckert, C., et al. (2001).
Minimum information about a microarray
experiment (MIAME)-toward standards for
microarray data. Nat. Genet. 29, 365–371. doi:
10.1038/ng1201-365
Gkoutos, G. V., Green, E. C. J., Mallon, A.-M.,
Hancock, J. M., and Davidson, D. (2004). Using
ontologies to describe mouse phenotypes. Genome
Biol. 6, R8. doi: 10.1186/gb-2004-6-1-r8
Gkoutos, G. V., Mungall, C., Dolken, S., Ashburner,
M., Lewis, S., Hancock, J., et al. (2009).
Entity/quality-based logical definitions for
the human skeletal phenome using PATO. Conf.
Proc. IEEE Eng. Med. Biol. Soc. 2009, 7069–7072.
doi: 10.1109/IEMBS.2009.533336
Hancock, J. M., and Dobbie, M. (2014). “Phenomics
of the laboratory mouse,” in Phenomics, ed J. M.
Hancock (Enfield, NH: Science Publishers/CRC
Press), 24–64.
Hancock, J. M., Mallon, A. M., Beck, T., Gkoutos,
G. V., Mungall, C., and Schofield, P. N. (2009).
Mouse, man, and meaning: bridging the semantics
of mouse phenotype and human disease. Mamm.
Genome 20, 457–461. doi: 10.1007/s00335-009-
9208-3
Howe, D. G., Bradford, Y. M., Conlin, T., Eagle, A.
E., Fashena, D., Frazer, K., et al. (2013). ZFIN, the
Zebrafish Model Organism Database: increased
support for mutants and transgenics. Nucleic
Acids Res. 41, D854–D860. doi: 10.1093/nar/
gks938
Kohler, S., Doelken, S. C., Mungall, C. J., Bauer, S.,
Firth, H. V., Bailleul-Forestier, I., et al. (2014).
The Human Phenotype Ontology project: linking
molecular biology and disease through pheno-
type data. Nucleic Acids Res. 42, D966–D974. doi:
10.1093/nar/gkt1026
Mayer, G., Montecchi-Palazzi, L., Ovelleiro, D., Jones,
A. R., Binz, P. A., Deutsch, E. W., et al. (2013).
The HUPO proteomics standards initiative- mass
spectrometry controlled vocabulary. Database
(Oxford) 2013, bat009. doi: 10.1093/database/
bat009
Morgan, H., Beck, T., Blake, A., Gates, H., Adams,
N., Debouzy, G., et al. (2010). EuroPhenome: a
repository for high-throughput mouse phenotyp-
ing data. Nucleic Acids Res. 38, D577–D585. doi:
10.1093/nar/gkp1007
Nigam, R., Laulederkind, S. J., Hayman, G. T., Smith,
J. R., Wang, S. J., Lowry, T. F., et al. (2013).
Rat Genome Database: a unique resource for rat,
human, and mouse quantitative trait locus data.
Physiol. Genomics 45, 809–816. doi: 10.1152/phys-
iolgenomics.00065.2013
Sansone, S. A., Rocca-Serra, P., Field, D., Maguire,
E., Taylor, C., Hofmann, O., et al. (2012). Toward
interoperable bioscience data. Nat. Genet. 44,
121–126. doi: 10.1038/ng.1054
Schofield, P. N., Gkoutos, G. V., Gruenberger, M.,
Sundberg, J. P., and Hancock, J. M. (2010).
Phenotype ontologies for mouse and man;
bridging the semantic gap. Dis. Model. Mech. 3,
281–289. doi: 10.1242/dmm.002790
Shimoyama, M., Nigam, R., Mcintosh, L. S.,
Nagarajan, R., Rice, T., Rao, D. C., et al. (2012).
Three ontologies to define phenotype measure-
ment data. Front. Genet. 3:87. doi: 10.3389/fgene.
2012.00087
Smith, C. L., and Eppig, J. T. (2012). The Mammalian
Phenotype Ontology as a unifying standard
for experimental and high-throughput pheno-
typing data. Mamm. Genome 23, 653–668. doi:
10.1007/s00335-012-9421-3
Soldatova, L. N., and King, R. D. (2006). An ontol-
ogy of scientific experiments. J. R. Soc. Interface 3,
795–803. doi: 10.1098/rsif.2006.0134
Steinbeck, C., Conesa, P., Haug, K., Mahendraker,
T., Williams, M., Maguire, E., et al. (2012).
MetaboLights: towards a new COSMOS of
metabolomics data management. Metabolomics 8,
757–760. doi: 10.1007/s11306-012-0462-0
Whetzel, P. L., Brinkman, R. R., Causton, H. C.,
Fan, L., Field, D., Fostel, J., et al. (2006a).
Development of FuGO: an ontology for functional
genomics investigations. OMICS 10, 199–204. doi:
10.1089/omi.2006.10.199
Whetzel, P. L., Parkinson, H., Causton, H. C., Fan, L.,
Fostel, J., Fragoso, G., et al. (2006b). The MGED
Ontology: a resource for semantics-based descrip-
tion of microarray experiments. Bioinformatics
22, 866–873. doi: 10.1093/bioinformatics/
btl005
Conflict of Interest Statement: The author declares
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 28 March 2014; accepted: 03 April 2014;
published online: 24 April 2014.
Citation: Hancock JM (2014) Commentary on
Shimoyama et al. (2012): three ontologies to define
phenotype measurement data. Front. Genet. 5:93. doi:
10.3389/fgene.2014.00093
This article was submitted to the journal Frontiers in
Genetics.
Copyright © 2014 Hancock. This is an open-access
article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, dis-
tribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited
and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Genetics www.frontiersin.org April 2014 | Volume 5 | Article 93 | 2
